Kim Ribeiro, Head of Diversity & Patient Inclusion, AbbVie says that building patient-centric teams that increase diverse representation in drug development clinical trials is her main achievement. She strives to make AbbVie the leader in the design of inclusive clinical research programs for patients and physicians. Kim’s success strategy is based on building partnerships with physicians, patients, and community groups that equals an approach that will ultimately lead to innovative and inclusive solutions that advance health equity.
Kim’s end goal is for diversity and inclusion to not be treated as a separate topic, because D&I is systematically integrated into every decision and at every stage of the clinical development process. She developed a plan that includes reviewing and assessing all aspects of AbbVie’s sponsored clinical trials, from the planning process to ensuring efforts to drive diversity apply to patients, clinicians, and partner organizations. Kim’s philosophy is that driving diversity requires more than empathy. It requires authenticity and curiosity to understand what diversity means to different stakeholders. Kim connects with a broad range of stakeholders to develop advocates who support these efforts.
FAVORITE QUOTE: “The goal is to die with memories and not dreams". — Anonymous